TBP.V) (TBPMF), a global leader in cannabinoid-based drug development and discovery, wishes to announce a change in the previously set time for the Corporation’s Meeting, which was originally scheduled for Thursday, June 20, 2019 at 2:00 p.m. (Eastern Daylight Time) .
TBP.V) (TBPMF) is a biopharmaceutical multifaced corporation with its primary focus in cannabinoid-based drug discovery and development with a clinical trial program aimed at bringing novel drugs and treatments to patients and their healthcare providers. Tetra Bio-Pharma’s subsidiary, Tetra Natural Health, also focuses on the development and commercialization of natural health and self-care products as well as the sale of its hemp energy drinks.
www.tetrabiopharma.com and www.tetranaturalhealth.com
SOURCE Tetra Bio-Pharma Inc
http://www.newswire.ca/en/releases/archive/June2019/17/c4062.html